Candel Therapeutics (NASDAQ:CADL) is developing off-the-shelf multimodal viral immunotherapies for individualized systemic anti-tumor immune response, specific to the patient’s difficult-to-treat cancer, improving...
OneMedNet (NASDAQ:ONMD) is delivering seamless access to regulatory-grade imaging real-world data (RWD) by employing its proprietary iRWD network and platform to de-identify, search, and curate data revealing an...
Closely-held Vizgen is pioneering next-generation genomics and benchmarking the spatial genomics field with its commercial MERSCOPE Platform, the industry’s first high plex in situ single-cell spatial genomics solution...
Conavi Medical’s reverse merger with Titan Medical (TSX: TMD; OTC: TMDIF), which is expected to close in July 2024, and concurrent financing are anticipated to cultivate an investor network to help fund the expansion of...
BioRestorative Therapies (NASDAQ:BRTX) is a fully integrated regenerative medicine company with preclinical and Phase 2 clinical programs focused on conditioning the bodies’ regenerative potential to treat major...
iBio (NYSEA:IBO) is developing next-generation biopharmaceuticals leveraging computational biology and 3D-modeling of epitopes enabling the discovery of new antibody treatments for hard-to-target cancers and other...
TriSalus Life Sciences (NASDAQ:TLSI) is addressing the mechanical and biologic barriers within the tumor microenvironment (TME) that make it challenging to successfully treat liver and pancreatic tumors.
Closely-held xNARA Biologics is reshaping the wellness industry through personalized health and wellness solutions designed to address genetic predispositions and disorders identified by analyzing individual DNA, gut...
Closely-held Simtra BioPharma Solutions, a premier contract development and manufacturing organization with more than 65 years of sterile injectable manufacturing experience, offers world-class cGMP sterile fill/finish...
As founder and executive chair of the non-profit Indo-US Organization for Rare Disease (IndoUSrare), Harsha Rajasimha, Ph.D., social entrepreneur, and subject matter expert in bioinformatics, data analysis, and...